Sign In

Alban Bessede, PhD

Immunologist, CEO of ImmuSmol, Explicyte Immuno-Oncology & Nobel Therapeutics

Alban Bessede is a seasoned professional with a diverse background in Immunology. He currently serves as the Chief Executive Officer at Explicyte & ImmuSmol. Prior to this role, he held a Post-doctoral fellowship at the University of New South Wales. Alban has a strong academic foundation, having completed his PhD in Immunology at the University of Perugia & University of Bordeaux.

Highlights

May 22 · linkedin

Next week at #ASCO24 in Chicago! No poster or presentation this year, just meetings. Feel free to drop me a line!

Apr 29 · linkedin

Back from ISTRY 2024 - the 16th International Society for Tryptophan Research Conference in Jena, Germany!

  • Had fun with scientists from Macquarie University (picture below with Bavani Gunasegaran, Shivani Krishnamurthy, Ruiwen Benjamin Heng). #EarthIsFlatTryptophanDoesNotExist ;)
  • Great discussions with the team of Christiane Opitz (DKFZ German Cancer Research Center in Heidelberg) and Stefano Comai (Università degli Studi di Padova)
  • Overall great sessions! Many thanks to the organizers and scientific committee! Ines Heiland Johanna Gostner Florian Daniel Zepf Kathrin Thedieck Sophie Erhardt Edwin (Chai) Lim Ana Pocivavsek

Related Questions

What are Alban Bessede's main achievements at Nobel Therapeutics?
How did Alban Bessede transition from Sydney to Bordeaux for his post-doc?
What inspired Alban Bessede to start Immusmol?
What are the key projects Alban Bessede is currently working on at Nobel Therapeutics?
How has Alban Bessede's work impacted the field of immuno-oncology?
Alban Bessede, PhD
Alban Bessede, PhD, photo 1
Alban Bessede, PhD, photo 2
Add to my network

Location

Bordeaux, Nouvelle-Aquitaine, France